An Urgent Need for Experimental Animal Model of Autism in Drug Development
Overview
Authors
Affiliations
Construct, face and predictive validities are necessary for any disease model. Although rodent models are used to investigate the neurobiology of autism, however, till date there is no such ideal animal model which can fulfill all the above said validities. Available drug therapy to treat autism is very limited and less effective. In this review, we summarize the work done with rodent models of autism and highlight different validities. We found that, very few studies have studied all the validities in a single study and none of the study fulfilled all the validities. We also reviewed the drugs used in the treatment of autism. Here we propose the limitations of available animal models. We also propose the urgent need of additional models to fulfill all the validities and to understand autism in a better way.
Smirnov K, Starkov I, Sysoeva O, Midzyanovskaya I Front Behav Neurosci. 2025; 18:1519486.
PMID: 39744143 PMC: 11688315. DOI: 10.3389/fnbeh.2024.1519486.
Selection of Young Animal Models of Autism over Adult: Benefits and Limitations.
Paudel R, Singh S Integr Psychol Behav Sci. 2021; 57(2):697-712.
PMID: 33447895 DOI: 10.1007/s12124-020-09595-4.
Birdsong as a window into language origins and evolutionary neuroscience.
Aamodt C, Farias-Virgens M, White S Philos Trans R Soc Lond B Biol Sci. 2019; 375(1789):20190060.
PMID: 31735151 PMC: 6895547. DOI: 10.1098/rstb.2019.0060.
Newer potential pharmacological targets for autism spectrum disorder.
Jain R, Prakash A, Medhi B Indian J Pharmacol. 2019; 51(4):284-286.
PMID: 31571718 PMC: 6759525. DOI: 10.4103/ijp.IJP_518_19.
Opportunities and challenges for intranasal oxytocin treatment studies in nonhuman primates.
Bauman M, Murai T, Hogrefe C, Platt M Am J Primatol. 2018; 80(10):e22913.
PMID: 30281820 PMC: 6690341. DOI: 10.1002/ajp.22913.